Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Medication and Psychotherapy Treatment Trial for Psychogenic Nonepileptic Seizures.

Next Previous
Trial Profile

Medication and Psychotherapy Treatment Trial for Psychogenic Nonepileptic Seizures.

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 20 Oct 2015

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Sertraline (Primary)
  • Indications Seizures
  • Focus Therapeutic Use
  • Acronyms NEST-T_1

Most Recent Events

  • 29 Aug 2012 Planned number of patients changed from 20 to 40.
  • 29 Aug 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
  • 26 Jul 2011 Planned end date changed from 1 Jun 2011 to 1 Jun 2013 as reported by ClinicalTrials.gov record.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top